Atlas Trials

3 yr Efficacy & Safety Study of Zoledronic Acid in Post-menopausal Women With Osteoporosis Treated With Zol Acid for 6 Yrs

Clinical trial NCT00718861 · COMPLETED

Trial details

NCT number
NCT00718861
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Post-menopausal Osteoporosis
Start date
2008-05-01
Primary completion
2013-04-01
Enrollment
190

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.